Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With A Reliable, Fast, Affordable Option For Patients
Published: Dec 11, 2013
SAN ANTONIO--(BUSINESS WIRE)--Invitae Corporation, a genetic diagnostics company, today announced at the 2013 San Antonio Breast Cancer Symposium that it now offers BRCA1 and BRCA2 testing globally, providing clinicians with a reliable, fast and affordable option for their cancer patients. Available with a turnaround time of just two weeks, this test includes full gene sequencing for both BRCA1 and BRCA2, as well as deletion/duplication analysis. The test is globally available and is priced at $1,500 in the United States.
Help employers find you! Check out all the jobs and post your resume.